Keywords: LEO Pharma, 4SC Discovery, Research and license deal, Skin diseases, Psoriasis

LEO Pharma and 4SC Discovery link for skin disease research

Article | 26 February 2013

Privately-held Danish dermatology specialist LEO Pharma has entered into an exclusive research and license agreement with the German biotech company 4 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

LEO Pharma

4SC Discovery

Go to company listing